Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Human Tendon Tissue Collection

18 de mayo de 2026 actualizado por: Queen Mary University of London

Human Tendon Tissue Collection for In Vitro Models and Tissue Analysis

The goal of this study is to improve understanding of tendon health and disease by using surplus tendon tissue that is routinely removed during planned orthopaedic surgeries in adults. The main questions it aims to answer are:

- What can tendon tissue and tendon cells tell us about how healthy and diseased tendons function?

Participants will not undergo any extra procedures. Instead, researchers will use only tissue that is already being removed as part of normal surgical care and would otherwise be discarded.

Participants will:

  • Be asked for permission (consent) before their surgery to donate any surplus tendon tissue.
  • Have a small piece of tendon tissue (normally waste material) collected during their planned operation.
  • Allow the research team to access some non-identifiable medical information (such as age, reason for surgery, and relevant medical history) to help interpret research findings.

What the researchers will do with the donated tissue:

  • Isolate different types of human tendon cells.
  • Build advanced laboratory cellular models to study how tendon diseases develop.
  • Analyse whole tendon tissue sections to understand cell types, tissue organisation, and disease-related changes.

This study does not involve testing treatments, and it does not change any aspect of a participant's clinical care. Although there is no direct benefit to participants, the donated tissue may help researchers develop better ways to study tendon injuries and improve future treatment options for tendon disease.

Descripción general del estudio

Descripción detallada

This study aims to improve our understanding of how human tendons work, why they become injured, and how tendon diseases develop. Tendon problems-such as tendinopathy-are common and can cause long-lasting pain and loss of mobility. Scientists currently lack good laboratory models that accurately represent real human tendon tissue, which makes it harder to study these conditions or test new treatments.

During many types of planned orthopaedic surgery, small pieces of tendon tissue are routinely removed because they are no longer needed for the patient's care. Normally, this tissue would simply be thrown away. In this study, patients who are already having surgery are invited to donate this surplus tissue for research.

How the study works:

If a patient agrees to take part, the healthcare team will collect the leftover tendon tissue during their planned operation. There are no extra procedures, no changes to the surgery, and nothing additional that the patient needs to do.

After collection, the tissue is taken to research laboratories at Queen Mary University of London. There, scientists use it in two main ways:

  1. Studying the tendon tissue itself:

    Researchers examine the structure and cells within the tendon to study how tendon cells are organised.

  2. Growing tendon cells in the lab:

The donated tissue allows researchers to isolate living tendon cells. These cells can then be used to build more advanced laboratory models-such as "tendon-on-a-chip" systems-that mimic how tendons experience movement, load, and interaction with other cell types. These models will help scientists study disease processes and could support the development of new treatments in the future.

To support this work, the research team also receives a small amount of non-identifiable medical information about each donor-such as age, general health information, and the reason for surgery. This helps researchers understand how different factors may influence tendon biology. All personal details (like names or NHS numbers) remain within the hospital and are never shared with the research team.

Why this research matters:

Human tendon tissue is rarely available for research, yet it is essential for creating accurate models and understanding real-world disease. By using tissue that would otherwise be discarded, this study will:

  • Provide new insights into how tendons function and how tendon diseases develop.
  • Help researchers design more realistic laboratory systems to study tendon conditions.
  • Support future work aiming to improve diagnosis, prevention, and treatment of tendon disorders.

Although participants will not directly benefit, their donated tissue may contribute to scientific progress that improves care for people with tendon injuries in the future.

Tipo de estudio

De observación

Inscripción (Estimado)

400

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Método de muestreo

Muestra no probabilística

Población de estudio

Patients scheduled to undergo orthopaedic lower limb surgery at the Royal London, Whipps Cross University Hospital and the Barts Health Orthopaedic Centre in Newham.

Descripción

Inclusion Criteria:

  • 18 years or older
  • Scheduled to undergo orthopaedic lower limb surgery that involve tendon tissue waste
  • Have provided informed consent to take part in the study

Exclusion Criteria:

  • Under the age of 18
  • Unable or unwilling to give informed consent (including those with limited English proficiency)
  • Cases where tendon tissue is required for clinical care and therefore not surplus.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Obtain sufficient tendon tissue samples.
Periodo de tiempo: Perioperative to immediate post-collection laboratory processing (within 24 hours).
The main outcome of this project is to obtain sufficient tendon tissue to isolate different human tendon cells and perform tissue analysis.
Perioperative to immediate post-collection laboratory processing (within 24 hours).

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Hazel Screen, Professor, PhD, Queen Mary University of London

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de junio de 2026

Finalización primaria (Estimado)

1 de junio de 2031

Finalización del estudio (Estimado)

1 de junio de 2031

Fechas de registro del estudio

Enviado por primera vez

1 de abril de 2026

Primero enviado que cumplió con los criterios de control de calidad

18 de mayo de 2026

Publicado por primera vez (Actual)

26 de mayo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

26 de mayo de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

18 de mayo de 2026

Última verificación

1 de mayo de 2026

Más información

Términos relacionados con este estudio

Palabras clave

Otros números de identificación del estudio

  • 368295

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

No individual participant data will be shared. All data used in the study are pseudonymised before transfer to the research team, and identifiable information remains within the NHS clinical environment. No IPD dataset suitable for external sharing will be generated.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir